Screener
Kura Oncology KURA Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Kura Oncology’s 10-Q, filed August 12, 2026.
- Filed
- Aug 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-346884
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Product revenue, net | $9,122 | — | $14,888 | — |
| Collaboration revenue | 11,752 | 15,288 | 24,251 | 29,396 |
| Total revenue | 20,874 | 15,288 | 39,139 | 29,396 |
| Operating Expenses | ||||
| Cost of product sales | 243 | — | 505 | — |
| Research and development | 61,891 | 62,785 | 127,154 | 118,758 |
| Selling, general and administrative | 31,750 | 25,169 | 63,305 | 48,004 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's total revenue?
- Kura Oncology (KURA) reported total revenue of $20.87M in Q2 2026.
- How has Kura Oncology's total revenue changed year-over-year?
- Kura Oncology's total revenue increased by 36.5% year-over-year, from $15.29M to $20.87M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Kura Oncology's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude